Therapy News and Research

RSS

Artificial womb may provide avenue to improve outcomes for extremely preterm infants

An artificial womb has been successfully used to incubate healthy baby lambs for a period of one week, and researchers hope the technology will one day be able to do the same for extremely premature babies.

17 Aug 2017

Smoking linked to increased risk of aneurysm recurrence after endovascular treatment

In a new study, researchers report people who have experienced an aneurysm have another reason to quit smoking.

17 Aug 2017

Sanford Health launches solid tumor oncolytic virus clinical trial

Sanford Health is the first site in the United States to launch a clinical trial using a genetically-engineered virus that aims to destroy therapy-resistant tumors.

17 Aug 2017

Scientists discover novel therapeutic strategy to treat aggressive subgroup of lung cancer

Research conducted by a team of Norton Thoracic Institute scientists on a novel therapeutic avenue for an aggressive and difficult to treat subgroup of lung cancer was published in the August 15, 2017 issue of Cancer Research.

17 Aug 2017

Research highlights need for expert treatment to manage subarachnoid hemorrhages

Research led by the head of the Barrow Neurological Institute and published in the July 20, 2017 issue of The New England Journal of Medicine reveals that subarachnoid hemorrhages, which are caused by ruptured brain aneurysms, account for 5-10 percent of all strokes and are best managed by experienced and dedicated experts at high-volume centers with neurosurgeons, endovascular surgeons and stroke neurologists.

17 Aug 2017

Immunotherapy drug shows favorable safety profile in patients with advanced small cell lung cancer

The immunotherapy drug pembrolizumab has demonstrated a favorable safety profile and "promising durable clinical activity" in pretreated patients who exhibit high levels of the PD-L1 protein in advanced stages of small cell lung cancer (SCLC) – an aggressive form of the disease

16 Aug 2017

UC Irvine pharmacology researchers unearth potential roots of schizophrenia

An abundance of an amino acid called methionine, which is common in meat, cheese and beans, may provide new clues to the fetal brain development that can manifest in schizophrenia, University of California, Irvine pharmacology researchers report in the journal Molecular Psychiatry.

16 Aug 2017

Vaginal estrogens do not increase cancer, cardiovascular disease risk in post-menopausal women

Women who have gone through menopause and who have been using a vaginal form of estrogen therapy do not have a higher risk of cardiovascular disease and cancer than women who have not been using any type of estrogen.

16 Aug 2017

BU scientist wins $231,000 AHA award to improve cardiovascular therapies

Vijaya B. Kolachalama, PhD, assistant professor of medicine at Boston University School of Medicine, has received a Scientist Development grant from the American Heart Association.

16 Aug 2017

Blood biopsy helps identify targetable genetic alterations in patients with cancer of unknown primary

Using fragments of circulating tumor DNA in blood, University of California San Diego School of Medicine researchers were able to identify theoretically targetable genetic alterations in 66 percent of patients with cancer of unknown primary (CUP), a rare disease with seven to 12 cases per 100,000 people each year.

16 Aug 2017

Compounds produced by creosote bush exhibit anti-parasitic activity against pathogenic protozoa

Researchers at Skaggs School of Pharmacy and Pharmaceutical Sciences at University of California San Diego and the University of Colorado Anschutz Medical Campus have found that compounds produced by the creosote bush, a desert plant common to the Southwestern United States, exhibit potent anti-parasitic activity against the protozoa responsible for giardia infections and an amoeba that causes an often-lethal form of encephalitis.

16 Aug 2017

Older people treated with electroconvulsive therapy for depression may not get relief from insomnia

Older people receiving electroconvulsive therapy for their depression likely will need an additional treatment if insomnia is one of their symptoms, researchers report.

16 Aug 2017

ICP monitoring does not improve favorable outcome rate in patients with severe TBI, study shows

A new study has shown that use of intracranial pressure (ICP) monitoring in patients with severe traumatic brain injury (TBI) was associated with a significant decrease in mortality, but it did not improve the rate of favorable outcomes.

16 Aug 2017

Lab-grown miniature blood vessels mimic rare Hutchinson-Gilford Progeria Syndrome

Biomedical engineers have grown miniature human blood vessels that exhibit many of the symptoms and drug reactions associated with Hutchinson-Gilford Progeria Syndrome -- an extremely rare genetic disease that causes symptoms resembling accelerated aging in children.

16 Aug 2017

Cancer treatment with alternative medicine can double risk of dying: Study finds

A new study has found that patients who choose cancer treatment with alternative medicine more than double the risk of dying in five years compared to those who chose conventional cancer treatment for the treatable cancers. The study is published in the Journal of the National Cancer Institute.

15 Aug 2017

Emory scientists use new tools to detect granulins for the first time inside cells

Emory University School of Medicine researchers have developed tools that enable them to detect small proteins called granulins for the first time inside cells.

14 Aug 2017

Mayo Clinic researchers discover new cause of treatment resistance in prostate cancer

Mayo Clinic researchers have identified a new cause of treatment resistance in prostate cancer. Their discovery also suggests ways to improve prostate cancer therapy. The findings appear in Nature Medicine.

14 Aug 2017

SBIR Fast-Track grant to fund study on new drug that targets cardiovascular diseases

The Exscien Corporation of Louisville, KY, in conjunction with LSU Health New Orleans Cardiovascular Center of Excellence, has been awarded an SBIR Fast-Track grant in the amount of $3.7 million over three years by the National Heart, Lung and Blood Institute.

14 Aug 2017

Study provides promising framework to anticipate drug resistance in cancer

Being able to predict the resistance or sensitivity of a tumor cell to a drug is a key success-factor of cancer precision therapy.

14 Aug 2017

Complex sugar molecules could help in early detection of tumors

Scientists from the University of Würzburg have synthesized a complex sugar molecule which specifically binds to the tumor protein Galectin-1. This could help to recognize tumors at an early stage and to combat them in a targeted manner.

14 Aug 2017

Therapy News and Research

Artificial womb may provide avenue to improve outcomes for extremely preterm infants

Smoking linked to increased risk of aneurysm recurrence after endovascular treatment

Sanford Health launches solid tumor oncolytic virus clinical trial

Scientists discover novel therapeutic strategy to treat aggressive subgroup of lung cancer

Research highlights need for expert treatment to manage subarachnoid hemorrhages

Immunotherapy drug shows favorable safety profile in patients with advanced small cell lung cancer

UC Irvine pharmacology researchers unearth potential roots of schizophrenia

Vaginal estrogens do not increase cancer, cardiovascular disease risk in post-menopausal women

BU scientist wins $231,000 AHA award to improve cardiovascular therapies

Blood biopsy helps identify targetable genetic alterations in patients with cancer of unknown primary

Compounds produced by creosote bush exhibit anti-parasitic activity against pathogenic protozoa

Older people treated with electroconvulsive therapy for depression may not get relief from insomnia

ICP monitoring does not improve favorable outcome rate in patients with severe TBI, study shows

Lab-grown miniature blood vessels mimic rare Hutchinson-Gilford Progeria Syndrome

Cancer treatment with alternative medicine can double risk of dying: Study finds

Emory scientists use new tools to detect granulins for the first time inside cells

Mayo Clinic researchers discover new cause of treatment resistance in prostate cancer

SBIR Fast-Track grant to fund study on new drug that targets cardiovascular diseases

Study provides promising framework to anticipate drug resistance in cancer

Complex sugar molecules could help in early detection of tumors

Evaluating new approaches for rare disease genomics

Expanding access to NMR with the Fourier 80 Duo

Advancing Intracellular Delivery with LumiPore®

Latest News